Teva Sandals, a Kenyan-owned company, announced that it will launch its “First World” line of shoes in Africa in October.
The shoes will be priced at $125, with a “slim fit” and “smooth outsole” to be available to African customers.
The company says it is targeting young people and the poor and will target women, African students and students from minority communities.
The launch is a big boost for Teva, which has been struggling to grow its business in Africa.
Teva is one of the top global players in the footwear market, and has been growing at a strong pace, making up almost half of the market.
Tevavapha, which is also a leading maker of shoes, said it is also working on an African product line.
“Our new shoes will give African consumers a choice, and we are focused on delivering the best in African design and technology,” said Teva president Nairobi Ncube.
The First World line will include three shoes, priced at around $75 each.
They will be made of lightweight materials, such as nylon and leather.
The first line will be released in September 2018.
Teavas shoes are currently available in Europe, the US, Japan and Australia.
TeVas shoes will launch in Africa, but will not be available in all markets.
Teava says it wants to build its global reach and is targeting low- and middle-income markets, where the shoes can help people save money on shoes.
Tevi has been one of Kenya’s biggest footwear brands since 2007, when it launched the first generation of Teva shoes.
It was one of several companies that invested heavily in the Kenyan market in the past few years, according to the country’s Ministry of Trade and Industry.
In 2018, the company said it had invested in about 10,000 manufacturing jobs and was expected to add 2,500 jobs by 2019.
Tevcab, which also owns and operates many of Kenya ‘s largest retailers, also said in a statement that it is committed to helping people find affordable footwear in all of its markets.
It will offer its shoes in a variety of colors and sizes, with sizes ranging from 4-10 in the US and the UK.
Tevo said it would also be launching in Africa by the end of 2018.